Financial Instruments

ASC 825 is the "overall" home for financial instruments guidance that does not fit elsewhere, and it does two main things: it permits the irrevocable, instrument-by-instrument fair value option (FVO) for eligible financial assets, financial liabilities, firm commitments, and written loan commitments with changes in earnings, and it requires incremental disclosures about fair value of financial instruments, concentrations of credit risk, and market risk (825-10). Subtopic 825-20 adds a distinct rule that registration payment arrangements are a separate unit of account — the underlying instrument is measured under other GAAP (e.g., 815-10, 815-40, 835-30) ignoring the contingency, while the contingent obligation follows the loss-contingency model of 450-20. The industry Subtopics tailor this framework: depository and lending institutions disclose face/contract amount, nature and terms, and collateral policies for instruments with off-balance-sheet credit risk (825-942); insurance entities record investment contract receipts as liabilities rather than revenue and disclose reinsurance credit-risk concentrations (825-944); and not-for-profit health care entities report FVO unrealized gains and losses within the performance indicator (825-954). The unifying idea is election-based fair value measurement plus transparency about risks (credit, market, off-balance-sheet) that the balance sheet alone does not reveal.

Subtopics

1. 10Overall99 ¶

   ASC 825-10 provides the overall guidance for financial instruments, containing two sets of rules: the fair value option (FVO), which lets any entity irrevocably elect, at specified election dates, to measure eligible financial assets, financial liabilities, firm commitments, and written loan commitments at fair value with changes in earnings; and incremental disclosures about the fair value of financial instruments, concentrations of credit risk, and market risk. The FVO is elected instrument by instrument, only for an entire instrument (not specific risks or cash flows), and is intended to mitigate earnings volatility from measuring related assets and liabilities differently without applying hedge accounting.

   0005101525354550556065
2. 20Registration Payment Arrangements32 ¶

   ASC 825-20 governs registration payment arrangements — agreements in which an issuer must file/obtain effectiveness of a registration statement (or obtain/maintain a stock exchange listing) for financial instruments and must transfer cash or shares to the counterparty if it fails. The core rule is that the arrangement is a separate unit of account: the underlying financial instruments are recognized and measured under other GAAP (e.g., 815-10, 815-40, 835-30) ignoring the contingent obligation, while the contingent obligation itself is recognized and measured under the loss-contingency model in Subtopic 450-20. Extensive disclosures are required even if payment is remote.

   0005152530355055
3. 942Financial Services—Depository and Lending6 ¶

   This Subtopic sets the disclosure requirements for depository and lending institutions that hold financial instruments with off-balance-sheet credit risk — loan commitments, standby letters of credit, financial guarantees, loans sold with recourse, and similar instruments. For each such instrument an entity must disclose the face or contract amount, the nature and terms (including credit and market risk, cash requirements, and related accounting policy), and its collateral policies. Instruments within the scope of Topic 815 (derivatives) are excluded.

   00051550
4. 944Financial Services—Insurance18 ¶

   This subtopic applies the financial instruments guidance to insurance entities, covering investment contracts and disclosures about concentrations of credit risk arising from reinsurance contracts. Amounts received under investment contracts are not revenue; they are recorded as liabilities and accounted for like interest-bearing or other financial instruments, with related deferred acquisition costs reported as an asset. Ceding entities must disclose credit risk concentrations for reinsurance recoverables and prepaid reinsurance premiums, and must disclose the carrying amount of securities deposited with state regulatory authorities.

   00051525455055
5. 954Health Care Entities4 ¶

   This subtopic gives industry-specific guidance on financial instruments for not-for-profit, business-oriented health care entities. Its single substantive rule is a presentation rule: when such an entity elects the fair value option, the resulting unrealized gains and losses must be reported inside the performance indicator (or within discontinued operations, as appropriate) rather than outside it.

   051545